Clinical trials
Completed Inflammation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,078 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 10 |
| 2001 | 11 |
| 2002 | 17 |
| 2003 | 27 |
| 2004 | 44 |
| 2005 | 47 |
| 2006 | 64 |
| 2007 | 68 |
| 2008 | 81 |
| 2009 | 95 |
| 2010 | 99 |
| 2011 | 112 |
| 2012 | 110 |
| 2013 | 108 |
| 2014 | 105 |
| 2015 | 104 |
| 2016 | 112 |
| 2017 | 105 |
| 2018 | 102 |
| 2019 | 101 |
| 2020 | 103 |
| 2021 | 102 |
| 2022 | 102 |
| 2023 | 83 |
| 2024 | 70 |
| 2025 | 43 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,078 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 21 |
| Appalachian State University | 19 |
| University of Florida | 19 |
| Radboud University Medical Center | 18 |
| University of Aarhus | 16 |
| Bausch & Lomb Incorporated | 15 |
| National Eye Institute (NEI) | 14 |
| Novo Nordisk A/S | 14 |
| University of California, Los Angeles | 14 |
| Massachusetts General Hospital | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 2,078 |
| Obesity | 176 |
| Cardiovascular Diseases | 125 |
| Insulin Resistance | 116 |
| Diabetes Mellitus, Type 2 | 82 |
| Pain | 81 |
| Metabolic Syndrome | 77 |
| Atherosclerosis | 67 |
| Diabetes Mellitus | 53 |
| Asthma | 52 |
Trials
Showing 1 to 25 of 2,078. Each trial links to its page on Pharma Observatory.
1,978 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.